• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks
    life science investing

    Boston Hosts Heaviest Concentration of Life Science Companies

    Charlotte McLeod
    Apr. 17, 2015 04:47PM PST
    Life Science Investing News

    Boston Business Journal reported that Boston now hosts the heaviest concentration of life science companies in the world. Interestingly, however, the state is between third and eighth in terms of total life science job growth.

    Boston Business Journal reported that Boston now hosts the heaviest concentration of life science companies in the world. Interestingly, however, the state is between third and eighth in terms of total life science job growth.

    As quoted in the market news:

    The state’s prominence seems to be evident in the recent decisions by companies like Shire Pharmaceuticals, Baxter International and GE Healthcare to expand their presence in the area. A decade ago, the Boston and Cambridge area appeared to be in a race with San Francisco for the right to call itself the world’s hub of life science firms. Today, as MLSC CEO Susan Windham-Bannister has said, ‘No one would have that argument with us.’

    And it’s not just Massachusetts that’s making that claim. The most recent annual ranking by the Genetic Engineering and Biotechnology News ranks Massachusetts as No. 1, whereas last year the state lost out to San Francisco. The ranking is based on five criteria, and GEN acknowledges that job growth is not the main reason for the Boston area’s dominance. Rather, the state’s ranking on the top of that list is based on levels of venture investment, NIH funding and lab space.

    Click here to read the full Boston Business Journal report.

    life science investinglife science companies
    The Conversation (0)

    Go Deeper

    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Microscopic view of stem cells.

    Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

    Latest News

    Numinus Wellness Announces Change of Auditor

    Repayment of Lind Facility with Successful Capital Raise

    Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing News Stocks

    Defence Therapeutics Class A

    DTC:CC

    Cloud DX

    CDX:CA

    BioHarvest Sciences

    BHSC:CNX

    Billy Goat Brands

    GOAT:CC

    Contakt World

    HELP:CNX
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES